Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidine

2006 ◽  
Vol 16 (21) ◽  
pp. 5542-5545 ◽  
Author(s):  
Maniyan Padmanilayam ◽  
Bernard Scorneaux ◽  
Yuxiang Dong ◽  
Jacques Chollet ◽  
Hugues Matile ◽  
...  
2013 ◽  
Vol 10 (8) ◽  
pp. 741-747 ◽  
Author(s):  
Roberta Soares ◽  
Roberta Corrales ◽  
Fernanda Lopes ◽  
Marcio Alves ◽  
Adilson Silva ◽  
...  

Chemosphere ◽  
1984 ◽  
Vol 13 (11) ◽  
pp. 1169-1175 ◽  
Author(s):  
Carl-Axel Nilsson ◽  
Ann Gudéhn

2021 ◽  
pp. 131937
Author(s):  
Purna Koteswara Rao Cherukumalli ◽  
Bhaskara Rao Tadiboina ◽  
Kali Charan Gulipalli ◽  
Srinu Bodige ◽  
Vishnu Nayak Badavath ◽  
...  

Heterocycles ◽  
1994 ◽  
Vol 39 (1) ◽  
pp. 361 ◽  
Author(s):  
Kuo-Hsiung Lee ◽  
Makoto Miyahara ◽  
Yoshiki Kashiwada ◽  
Xin Guo ◽  
Hong-Xing Chen ◽  
...  

Author(s):  
Ishwar Bhat K ◽  
Abhishek Kumar

Objective: Many derivatives of pyrimidine are known for the broad-spectrum biological activities such as antimicrobial, antitumor, antibacterial, antitubercular, anti-inflammatory, and cytotoxic activity. Chalcones with an enone group show potent pharmacological activities such as antiinflammatory, antibacterial, antifungal, and antimalarial activity. A series of pyrimidines from chalcones have been synthesized and screened for anti-inflammatory and cytotoxic activity studies.Methods: Chalcones [1-(4-nitrophenyl)-3-substituted-phenylprop-2-en-1-one] were synthesized from various substituted aldehydes with 4-nitroacetophenone and cyclized with urea and glacial acetic acid to give pyrimidine derivatives [4-(4-nitrophenyl)-6-substituted-phenylpyrimidin-2-ol].Results: Anti-inflammatory and cytotoxic activity studies revealed that some of the synthesized compounds have shown significant activity.Conclusion: The observed results proved that pyrimidines are found to be interesting lead molecules for the synthesis of anti-inflammatory and cytotoxic agents


2020 ◽  
Vol 132 (1) ◽  
Author(s):  
Venugopalarao Vikram ◽  
Srinivasa R Penumutchu ◽  
Raviraj Vankayala ◽  
Suresh Thangudu ◽  
Karteek Rao Amperayani ◽  
...  

1994 ◽  
Vol 29 (6) ◽  
pp. 431-439 ◽  
Author(s):  
E Sartori ◽  
F Camy ◽  
JM Teulon ◽  
F Camborde ◽  
J Meignen ◽  
...  

Parasitology ◽  
2000 ◽  
Vol 121 (3) ◽  
pp. 237-246 ◽  
Author(s):  
M. B. HOSHEN ◽  
K. NA-BANGCHANG ◽  
W. D. STEIN ◽  
H. GINSBURG

Although artesunate, one of the potent derivatives of the qinghaosu family of drugs for treating falciparum malaria, is already in use in the field, its therapeutic protocol has only been developed empirically by hit-or-miss. A pharmacokinetic–pharmacodynamic (PK–PD) model, required for creating such a protocol, is not straightforward. Artesunate presents extremely fast pharmacokinetics. As a result the stage specificity of its action must be treated explicitly. Also, use of standard PK–PD modelling fails to explain the clinical results. Our PK–PD modelling of its activity leads us to the postulation of the existence of a novel effect: a small fraction of the parasites, as a result of chemotherapeutic pressure, become cytostatic, or ‘dormant’. At this stage, the parasite cycle is halted, making them unsusceptible to further dosing until wakening. This slows down the antimalarial activity of the drug, entailing either many frequent doses or an extended period of treatment and surveillance. Based on our modelling, we suggest a method for deciding on rational models of chemotherapy against falciparum malaria.


Sign in / Sign up

Export Citation Format

Share Document